3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Myelodysplastic Syndromes
111
Leukemia, Myeloid, Acute
106
Leukemia
67
Leukemia, Myelomonocytic, Chronic
35
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
35
Myeloproliferative Disorders
30
Anemia, Refractory, with Excess of Blasts
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
28
Blast Crisis
24
Leukemia, Myeloid, Chronic-Phase
21
Congenital Abnormalities
20
Myelodysplastic-Myeloproliferative Diseases
15
Lymphoma
14
Leukemia, Myeloid, Accelerated Phase
14
Lymphoma, Non-Hodgkin
13
Leukemia, Biphenotypic, Acute
13
Leukemia, Monocytic, Acute
12
Leukemia, Myelomonocytic, Acute
11
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
11
Leukemia, Megakaryoblastic, Acute
11
Leukemia, Erythroblastic, Acute
11
Hodgkin Disease
11
Recurrence
8
Primary Myelofibrosis
8
Multiple Myeloma
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Burkitt Lymphoma
8
Lymphoma, Mantle-Cell
7
Lymphoma, Large-Cell, Immunoblastic
7
Lymphoma, Large B-Cell, Diffuse
7
Interventions
Etoposide
7
pegaspargase
5
Methylprednisolone
4
Dexamethasone
4
Cyclophosphamide
3
Alemtuzumab
3
Gemcitabine
2
Flow Cytometry
2
Emapalumab
2
Doxorubicin
2
zanubrutinib
1
tocilizumab
1
sintilimab
1
ruxolitinib
1
fludarabine phosphate
1
fludarabine
1
Whole-Body Irradiation
1
Vincristine
1
Thiotepa
1
Th1-Th2 Balance
1
Tacrolimus
1
Rituximab
1
Prednisone
1
Polymerase Chain Reaction
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Methylprednisolone Hemisuccinate
1
Methotrexate
1
Melphalan
1
In Situ Hybridization
1
Immunohistochemistry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphohistiocytosis, Hemophagocytic
×
Cytarabine
×
Myeloid
×
Clear all
NCT00368355
2020-01-21
MOHEL
Baylor College of Medicine
Phase 2
Completed
46 enrolled
12 charts